A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions

Microbial Biotechnology
D R AlvesA Tobias A Jenkins

Abstract

Pseudomonas aeruginosa is an opportunistic human pathogen that forms highly stable communities - biofilms, which contribute to the establishment and maintenance of infections. The biofilm state and intrinsic/acquired bacterial resistance mechanisms contribute to resistance/tolerance to antibiotics that is frequently observed in P. aeruginosa isolates. Here we describe the isolation and characterization of six novel lytic bacteriophages: viruses that infect bacteria, which together efficiently infect and kill a wide range of P. aeruginosa clinical isolates. The phages were used to formulate a cocktail with the potential to eliminate P. aeruginosa PAO1 planktonic cultures. Two biofilm models were studied, one static and one dynamic, and the phage cocktail was assessed for its ability to reduce and disperse the biofilm biomass. For the static model, after 4 h of contact with the phage suspension (MOI 10) more than 95% of biofilm biomass was eliminated. In the flow biofilm model, a slower rate of activity by the phage was observed, but 48 h after addition of the phage cocktail the biofilm was dispersed, with most cells eliminated (> 4 logs) comparing with the control. This cocktail has the potential for development as a therapeutic...Continue Reading

References

Feb 1, 1991·Infection and Immunity·J M TerryS J Mattingly
May 1, 1991·Archives of Internal Medicine·L A Dever, T S Dermody
Mar 1, 1969·Journal of Virology·P F Bartell, T E Orr
Mar 1, 1981·Applied and Environmental Microbiology·T W HejkalP A LaRock
Jan 1, 1995·Annual Review of Biochemistry·Z Kelman, M O'Donnell
Aug 1, 1995·FEMS Microbiology Reviews·R Young, U Bläsi
Oct 6, 2000·Annual Review of Microbiology·I N WangR Young
Sep 19, 2003·Applied Microbiology and Biotechnology·Y TanjiH Unno
Oct 1, 1961·Journal of General Microbiology·R G TUCKER
Nov 19, 2003·Microbes and Infection·Eliana Drenkard
Nov 1, 2005·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Shigenobu MatsuzakiShosuke Imai
Nov 26, 2005·Archives of Virology·M X YuH-W Ackermann
Feb 1, 1967·Proceedings of the National Academy of Sciences of the United States of America·G StreisingerM M Stahl
Dec 19, 2007·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Garth A JamesPhilip S Stewart
Feb 12, 2008·BMC Genomics·Ramy K AzizOlga Zagnitko
May 23, 2008·PLoS Biology·Sivan PearlNathalie Q Balaban
Jun 11, 2008·Research in Microbiology·Nicholas H Mann
Feb 24, 2009·Journal of Microbiological Methods·Elke LammensGuido Volckaert
Jun 17, 2009·Journal of Medical Microbiology·Tanya Strateva, Daniel Yordanov
Aug 15, 2009·Environmental Microbiology·Pieter-Jan CeyssensRob Lavigne
Jan 1, 2009·Current Pharmaceutical Biotechnology·Elizabeth KutterStephen T Abedon
Mar 30, 2010·Nature Reviews. Microbiology·Simon J LabrieSylvain Moineau
Jun 18, 2010·Environmental Microbiology·Eliane FrimmersdorfDietmar Schomburg
Feb 4, 2011·Epidemiologic Perspectives & Innovations : EP+I·Joseph H Abramson
Feb 18, 2011·Applied Microbiology and Biotechnology·Zuzanna Drulis-KawaAndrew M Kropinski
Mar 17, 2011·Nature Reviews. Microbiology·Michael A McGuckinTimothy H Florin
Jul 20, 2011·Research in Microbiology·Gipsi Lima-MendezRaphael Leplae
Jul 26, 2011·Research in Microbiology·Diana PiresJoana Azeredo
May 1, 2012·Journal of Microbiological Methods·Ping ChenKai P Leung
Jul 12, 2012·The Journal of Antimicrobial Chemotherapy·Ea ZankariMette Voldby Larsen
Jan 29, 2014·Virology Journal·Johannes WittmannChristine Rohde
Feb 8, 2014·Genome Announcements·Diana P PiresSanna Sillankorva
Feb 28, 2014·Journal of Clinical Microbiology·Katrine Grimstrup JoensenFrank M Aarestrup

❮ Previous
Next ❯

Citations

Aug 2, 2016·Environmental Science & Technology·Sanly LiuRose Amal
Jun 22, 2018·Current Reviews in Musculoskeletal Medicine·Mariam TahaAlberto V Carli
Jun 17, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Bartłomiej GrygorcewiczBarbara Dołęgowska
Jul 24, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edison J CanoGina A Suh
May 31, 2019·Biofouling·Legesse Geredew KifelewPeter Speck
May 28, 2020·Antibiotics·Celia Ferriol-González, Pilar Domingo-Calap
Sep 15, 2020·Frontiers in Cellular and Infection Microbiology·Reham WasfiLamiaa Ismail Fahmy
Mar 5, 2017·Postȩpy higieny i medycyny doświadczalnej·Fairoz Al-WrafyAndrzej Gamian
May 18, 2018·Frontiers in Microbiology·Giantommaso ScarasciaPei-Ying Hong
Oct 2, 2020·Annals of Clinical Microbiology and Antimicrobials·Zahra CheginiAref Shariati
Oct 4, 2020·Antibiotics·Johannes WittmannEvelien M Adriaenssens
Dec 3, 2020·Expert Review of Anti-infective Therapy·Amrita PatilSunil Saroj
Jan 29, 2021·Infection and Drug Resistance·Fengjuan TianYigang Tong
Dec 31, 2020·Antibiotics·Cristina UruénJesús Arenas
Jan 26, 2021·Frontiers in Cellular and Infection Microbiology·Christopher J R TurkingtonJuris A Grasis
Mar 24, 2021·Journal of the Pediatric Infectious Diseases Society·Pranita D Tamma, Gina A Suh
Jul 3, 2021·Viruses·Stephen T AbedonMatthew B Sullivan
Jul 2, 2021·Environmental Microbiology Reports·Sandhya Rai, Amod Kumar
Jul 27, 2021·Biofouling·Camila Mendes FigueiredoEdvaldo Antonio Ribeiro Rosa
Aug 8, 2021·International Journal of Molecular Sciences·Ana C AfonsoManuel Simões

❮ Previous
Next ❯

Methods Mentioned

BETA
transmission electron microscopy

Software Mentioned

resfinder
ImageJ
rtemis
LSM Image Browser
imaris
rast
CLC Genomic Workbench
virulencefinder
blast
winpepi

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.